HemoShear Therapeutics was acquired by Virginia Capital Partners And Main Line Equity Partners on September 1, 2012

Medical Products Company

Out of 60 sectors in the Mergr database, medical products ranked 10 in number of deals in 2012. The largest medical products acquisition in 2012 was Pharmaco Hf. - which was acquired by Watson Pharmaceuticals for $4.8B.

Join Mergr to view all 197 acquisitions of medical products companies in 2012, including 30 acquisitions by private equity firms, and 167 by strategics.

HemoShear Therapeutics LLC

501 Locust Ave., Suite 301,
Charlottesville, Virginia 22902
United States,
(434) 872-0196
www.hemoshear.com

HemoShear Therapeutics LLC is a provider of human surrogate testing device that replicates the anatomical structure of the human blood vessel wall and blood flow patterns, providing superior pre-clinical drug response data than is currently available through traditional cell culture and animal testing processes.


 Subscribe to unlock this and 164,188
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 153K M&A Transactions
  • 160K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 49K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.